Cardiac remodeling describes a series of structural and functional changes in the heart after
myocardial infarction (MI). Adverse post‐MI cardiac remodeling directly jeopardizes the …

Myocardial infarction (MI) remains one of the leading cause of mortality over the world.
However, current treatments are more palliative than curative, which only stall the …

Despite the success of current therapies for acute myocardial infarction (MI), many patients
still develop adverse cardiac remodeling and heart failure. With the growing prevalence of …

Injectable hydrogel biomaterials are promising therapies to promote repair and regeneration
post-myocardial infarction (MI). However, the timing of delivery and the mechanisms through …

Injectable biodegradable hybrid hydrogels were designed and developed based on
thiolated collagen (Col-SH) and multiple acrylate containing oligo (acryloyl carbonate)-b …

Integrins are a family of heterodimeric proteins expressed by cardiac fibroblasts and
cardiomyocytes that provide critical adhesive and signaling functions through their …

Methylglyoxal (MG) is a highly reactive dicarbonyl and the main precursor of advanced
glycation end‐products (AGEs). After myocardial infarction (MI), MG‐derived AGEs …

Although cocooning explant-derived cardiac stem cells (EDCs) in protective nanoporous
gels (NPGs) prior to intramyocardial injection boosts long-term cell retention, the number of …

Currently, the clinical impact of cell therapy after a myocardial infarction (MI) is limited by low
cell engraftment due to low cell retention, cell death in inflammatory and poor angiogenic …

The goal of this study was to develop strategies to localize human collagen-based hydrogels
within an infarcted mouse heart, as well as analyze its impact on endogenous extracellular …